Skip to content
PulseMS
Log inJoin
Research & community

MS research, together.

MS research in plain English. Perspectives from people who understand.

Research evidence filters

Filters apply to reviewed research. Unknown dates and unassessed posts are excluded when a corresponding filter is active.

Reset filters
Topics & sourcesFiltered
Research and community updates, newest first.#NeuroinflammationAI researchClear filters
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyNot reportedTrial registry

Study of Disability Mechanisms in Immune-Mediated CNS Disorders Including Humans

This study is designed to explore how disability develops in people with immune-mediated injuries to the central nervous system (CNS). It involves 2400 subjects, including both patients showing symptoms of CNS damage and healthy volunteers for comparison. Patients may also have follow-up tests with NIH researchers after 1-2 years.

What this does not proveThe study has not posted any results, and its planned enrollment and endpoints do not constitute findings.
#Neuroinflammation
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyAnimal studyPreclinicalPeer review unconfirmed

Animal and Human Studies on Specialized Pro-Resolving Mediators in MS

Research indicates that specialized pro-resolving mediators (SPMs), such as resolvins, lipoxins, and maresins, can reduce neuroinflammation, prevent demyelination, and restore immune balance. Human studies show systemic deficiencies in lipid resolution pathways with increased pro-inflammatory eicosanoids.

What this does not proveKey questions remain about the causes of resolution failure, its varying dynamics at different disease stages, and the applicability of SPM interventions in human patients.
#Neuroinflammation
View abstract on PubMedPMID 42839044AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedSystematic reviewPeer review unconfirmed

Mast Cell Activity in Neuroinflammation: Implications from a Systematic Review

A systematic review discusses the role of mast cells in neuroinflammation, noting their contributions to multiple sclerosis and other neurological conditions. It suggests that adjusting mast cell activity could be a promising therapeutic strategy to manage neuroinflammatory damage.

What this does not proveThe review does not provide evidence of direct clinical efficacy for mast cell targeting in multiple sclerosis and lacks specific human trial data to support its conclusions.
#Neuroinflammation
View abstract on PubMedPMID 42835139AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyInterventionalPeer-reviewed

Effects of Oral Cladribine on TSPO Availability in Individuals with RRMS

In a small study, 14 participants with relapsing-remitting multiple sclerosis (RRMS) showed a 21% increase in TSPO availability in normal-appearing white matter and a 16% increase in the whole brain over 18 months. Additionally, their median annualized relapse rate significantly decreased from 0.67 to 0.00, and serum neurofilament light chain levels improved.

What this does not proveThis is a small, single-arm pilot study, and findings may not indicate comprehensive efficacy or safety of cladribine in managing RRMS pathology.
#Neuroinflammation
View abstract on PubMedPMID 42814343AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedAnimal studyPreclinicalPeer-reviewed

Mouse Study on Porphyromonas gingivalis-Induced Periodontitis and EAE

In a study with mice, it was found that Porphyromonas gingivalis-induced periodontitis significantly aggravated neurological deficits associated with experimental autoimmune encephalomyelitis (EAE) over a follow-up of 15 to 21 days. The study also noted increased T cell infiltration in the spinal cord and activation of NF-κB signaling pathways.

What this does not proveThe results stem from an animal model, which may not directly apply to humans, and further research is needed to understand the implications for human health.
#Neuroinflammation
View abstract on PubMedPMID 42807870AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedAnimal studyPreclinicalPeer-reviewed

Neutrophil Heterogeneity in Mouse Model of Multiple Sclerosis

In a study using the EAE model, it was found that neutrophils in the spleen and bone marrow gain both CD4+ T cell suppressive capabilities and promote Th17 responses. Different neutrophil subsets were identified, with specific subsets showing immunosuppressive or pro-inflammatory activities, heavily influenced by the tissue environment.

What this does not proveThe study does not establish direct implications for human MS beyond observation in patients.
#Neuroinflammation
View abstract on PubMedPMID 42784888AI summary of a published abstract. Not medical advice.